EV
Evotec SE
EVOTF · OTC
$6.69 +0.00% (+$0.00)
Market Cap 1.02B €
P/E Ratio -
Div. Yield -
ROE 26.50%
Piotroski F-Score Moderate
4/9Valuation
96 /100
Cheap P/B 1.54x
P/S 1.42x
EV/EBITDA N/A
Growth
22 /100
Declining Book val. growth 11.84%
Rev. growth 1.60%
FCF growth N/A
Profitability
1 /100
Weak Net margin 27.52%
Op. margin 17.69%
FCF margin 22.56%
Quality
6 /100
Poor ROE 26.50%
ROA 12.56%
Asset turnover 0.46x
Debt
54 /100
Moderate Current ratio 2.33x
Int. coverage -10.81x
Debt/Equity 0.71x
Stability
45 /100
Moderate Rev. volatility 2.57%
EPS volatility 107.59%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EVOTF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Christian Wojczewski
Employees
4,553
Headquarters
Hamburg
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report